Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
October 28, 2020

Aurinia begins voclosporin trial in kidney transplant recipients with Covid-19

Aurinia Pharmaceuticals has announced the commencement of an open-label exploratory trial to assess antiviral activity of voclosporin in kidney transplant recipients (KTRs) with Covid-19.

Aurinia has announced initiation of voclosporin trial in kidney transplant recipients with Covid-19. (Credit: Gerd Altmann from Pixabay)